|
|
|
4. Adverse effects of levodopa/carbidopa intrajejunal gel treatmentTomaž Rus, Maša Premzl, Nina Zupančič-Križnar, Milica Gregorič Kramberger, Robert Rajnar, Lidija Ocepek, Zvezdan Pirtošek, Maja Trošt, 2022, izvirni znanstveni članek Ključne besede: advanced Parkinson's disease, levodopa-carbidopa intestinal gel, percutaneous endoscopic gastrojejunostomy, adverse effects, health-related quality of life
Celotno besedilo (datoteka, 1,14 MB) Gradivo ima več datotek! Več... |
5. Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's diseaseSara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, izvirni znanstveni članek Ključne besede: Parkinson's disease, genetic polymorphism, dopaminergic pathway, personalized medicine, adverse events
Celotno besedilo (datoteka, 411,70 KB) Gradivo ima več datotek! Več... |
6. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's diseaseSara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, izvirni znanstveni članek Ključne besede: Parkinson's disease, susceptibility, polymorphism, inflammation, oxidative stress, adverse events
Celotno besedilo (datoteka, 673,75 KB) Gradivo ima več datotek! Več... |
7. Genetic polymorphisms in oxidative stress and inflammatory pathways as potential biomarkers in Alzheimer’s disease and dementiaDavid Vogrinc, Milica Gregorič Kramberger, Andreja Emeršič, Saša Čučnik, Katja Goričar, Vita Dolžan, 2023, izvirni znanstveni članek Ključne besede: Alzheimer’s disease, oxidative stress, inflammation, polymorphism, biomarker
Celotno besedilo (datoteka, 1,14 MB) Gradivo ima več datotek! Več... |
8. Investigation of paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in Parkinson’s diseaseBoštjan Petrič, Sara Redenšek Trampuž, Vita Dolžan, Milica Gregorič Kramberger, Maja Trošt, Nikola Maraković, Marko Goličnik, Aljoša Bavec, 2023, izvirni znanstveni članek Ključne besede: Parkinson disease, cognitive impairment, paraoxonase 1, paraoxonase activity, single-nucleotide polymorphisms, iFIT
Celotno besedilo (datoteka, 1,14 MB) Gradivo ima več datotek! Več... |
9. Validation of the Slovenian version of the Montreal Cognitive Assessment Scale as a screening tool for the detection of mild cognitive impairmentAndreja Špeh, Irena Kalar, Zvezdan Pirtošek, Milica Gregorič Kramberger, 2024, izvirni znanstveni članek Ključne besede: mild cognitive impairment, MoCA, screening, cognition, elderly
Celotno besedilo (datoteka, 435,23 KB) Gradivo ima več datotek! Več... |
10. The association of selected GWAS reported AD risk loci with CSF biomarker levels and cognitive decline in Slovenian patientsDavid Vogrinc, Milica Gregorič Kramberger, Andreja Emeršič, Saša Čučnik, Katja Goričar, Vita Dolžan, 2023, izvirni znanstveni članek Ključne besede: Alzheimer's disease, mild cognitive impairment, polymorphism, biomarker
Celotno besedilo (datoteka, 1,48 MB) Gradivo ima več datotek! Več... |
